Overview
Lipid Systems Sp. z o.o. works with liposome technologies and liposomes used as carriers. The company is based in Wrocław, Poland.
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $229,967 | |
| Profit allocation | Dividend and reserves | |
| Loans and borrowings | $2,623,115 | |
| Capital expenditure | $54,097 | |
| Foreign sales | 90.86% of revenue ($4,019,368) | |
| Revenue structure | Wyroby gotowe |
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 94 days for 2021).
- 202516/07/2026
- 202415/07/2025
- 202316/07/2024
- 202215/07/2023
- 202117/10/2022
- 202013/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
News

Supportive Care solutions presented at Vita Foods 2024 in Geneva by Lipid Systems!
New distribution agreement signed.
Lipid Systems has acquired a new Partner for distribution in Israel. Welcome on board!
11-19.10.2023 – CPHI-related B2B meetings in Wrocław
We had a pleasure to host on-site in Wrocław GMP facility some of our most valued business partners / distributors. Thank you for your input and confidence in our technology! New products are on its way!
EPO intention to grant patent protection for LipoShell® technology.
European Patent Office after extensive examination of LipoShell ® patent application has issued intention to grant a patent protection under Rule 71(3) EPC.
Grant of patent protection for LipoShell® technology in Australia
Grant of patent protection for LipoShell® technology in the US
Industry
Websites
- lipidsystems.plLIPID SYSTEMS – technologie liposomoweWordPress 6.5Nginx
Public procurement
1 tender recorded as contractor, with a total value of $15,506.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Jun 2, 2025 | Supply of synthesized liposomes containing a contrast agent for magnetic resonance imaging (MRI), for the needs of Jagiellońskie Centrum Rozwoju Leków (jcet) in Kraków. | $15,506$15,506 | Uniwersytet Jagielloński |
Trademarks
The company holds 7 active trademarks registered with the Polish Patent Office. The first mark was filed in 2015.
| Mark | Protected until | |
|---|---|---|
| ASCOLIP (word) | Apr 17, 2030 | |
| VITA-D-LIP (word) | May 9, 2028 | |
| FE-LIP (word) | May 9, 2028 | |
| ASCOLIP (word) | Aug 22, 2027 | |
| Sonosome (word) | Nov 16, 2035 |
Authorized Representatives
Manner of representation
Each member of the management board is authorized to represent the company individually.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 32,050 | $432,874.12 | 47.9231% | |
Twiti Investments Ltd. | 33,439 | $451,634.25 | 50% |
Others | 1,389 | $18,760.13 | 2.0769% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Lipotech sp. z o.o. | 1,350.62 USD | 100% |
Capital group
The company belongs to the Twiti Investments Limited (Cyprus) group, which is its direct owner.
Bank accounts
Registered as a VAT taxpayer on 2011-10-10.
48 1240 6410 1111 0010 8402 1545
17 1240 6410 1111 0010 8402 1327
94 1240 6074 1978 0011 0792 3249
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $387.1K$387,081 |
Buildings and premises | $1.4M$1,358,449 |
Public aid
18 public aid cases recorded, with a total value of $4,518,154.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Oct 27, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $13,632$13,632 | Prezes Banku Gospodarstwa Krajowego | |
| May 8, 2025 | Aid for research and development projects: industrial research | $880.2K$880,164 | Marszałek Województwa Śląskiego | |
| May 8, 2025 | Aid for research and development projects: experimental development | $227.9K$227,866 | Marszałek Województwa Śląskiego |
European Funds
7 projects recorded: 4 from FE lists ($7,315,133) and 3 Commission grants (FTS) ($1,158,780).
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2025-02-01 | Development of an innovative lipid base with radioprotective effects | $2.4M$2,394,877 | European Funds for Śląskie 2021-2027 | |
| 2024-12-01 | Research into a liposomal form of iron using proprietary technological solutions to implement a medicinal product based on liposomal nanotechnology. | $2.6M$2,572,409 | European Funds for a Modern Economy | |
| 2022-09-01 | Cardiac regeneration by mrna-triggered proliferation of cardiomyocytes | $695.3K$695,268 | 1.0.11 - Horizon Europe |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Sieć Badawcza Łukasiewicz - Port Polski Ośrodek Rozwoju Technologii Research institute | $24,232,583.73 | port.lukasiewicz.gov.pl | ||
| Sieć Badawcza Łukasiewicz - Instytut Materiałów Polimerowych Research institute | $7,327,673.79 | impib.pl | ||
| Alioth Training sp. z o.o. | $7,311,989.87 | aliothgroup.pl | ||
| JJP Biologics sp. z o.o. | $4,998,735.31 | jjpbiologics.com | ||
| Centrum Badań I Rozwoju Technologii dla Przemysłu S.A. | $3,187,649.05 | cbrtp.pl | ||
| Centrum Badawczo-Rozwojowe Novasome sp. z o.o. | $3,159,753.62 | novasome.pl | ||
| Captor Therapeutics S.A. | $2,286,539.43 | captortherapeutics.pl | ||
| Aslab Science P.S.A. | $1,504,132.17 | aslabsci.com | ||
| Pikralida sp. z o.o. | $1,151,165.63 | pikralida.eu | ||
| Syvento sp. z o.o. | $970,435.47 | syvento.com |
Change history
| Date | Event | |
|---|---|---|
| 2020-01-29 | Share capital increase (3,205,000.00 PLN → 3,343,900.00 PLN) | |
| 2016-10-07 | Address change (Ul. Krzemieniecka 48b, 54-613, Wrocław → Ul. Krzemieniecka 48c, 54-613, Wrocław) | |
| 2016-07-20 | Address change (Duńska 9, 54-427, Wrocław → Ul. Krzemieniecka 48b, 54-613, Wrocław) | |
| 2016-07-20 | Share capital increase (3,200,000.00 PLN → 3,205,000.00 PLN) | |
| 2016-07-20 | PKD change (Removed: 7 codes; Added: 1 code) |
FAQ
Last updated: 2026-07-17